Ads
related to: paid clinical trialssas.com has been visited by 100K+ users in the past month
- SAS Viya
Better decisions, faster outcomes.
Try SAS Viya for free.
- How to Buy
Request Demos, Pricing, & Free
Software Trials. Learn More Today.
- Contact Us
Let SAS® Help. Contact Us to Learn
More or Talk to a SAS® Expert Today
- SAS Solutions
Real Solutions Powered by Real
Innovation. Learn More Today.
- SAS Viya
Search results
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 5 hours agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 13 hours ago-Positive Interim Clinical Trial Data for the First Oculopharyngeal Muscular Dystrophy (OPMD) Subject Dosed with BB-301 in the Phase 1b/2a Clinical ...
Earnings call: Intellia Therapeutics reports robust Q1 progress
Investing.com· 5 days agoIntellia Therapeutics (NASDAQ: NASDAQ: NTLA ) has made significant progress in the first quarter of...
Earnings call: Anavex Life Sciences eyes Alzheimer's, Rett syndrome trials By Investing.com
Investing.com· 4 days agoAnavex Life Sciences Corp. (NASDAQ:AVXL) held its fiscal 2024 second-quarter earnings call,...
Research on the cutting edge: Several therapies to treat liver conditions
Local 12 Cincinnati· 11 hours agoResearchers are looking for people who may have fatigue and pain linked to liver problems. Free help...
Earnings call: Achieve Life Sciences reports progress on cytisinicline trials By Investing.com
Investing.com· 3 days agoAchieve Life Sciences (NASDAQ:ACHV), a clinical-stage pharmaceutical company, has made significant...
Earnings call: Cumberland Pharmaceuticals highlights steady Q1 demand By Investing.com
Investing.com· 6 hours agoCumberland Pharmaceuticals Inc. (NASDAQ:CPIX) reported its financial results for the first quarter...
Earnings call: Protalix BioTherapeutics Q1 2024 financial results
Investing.com· 4 days agoProtalix BioTherapeutics, Inc. (PLX) has reported its first-quarter financial results for 2024,...
Takeda pays AC Immune $100M upfront for Alzheimer's drug as phase 2 readout nears
FierceBiotech· 16 hours agoThe asset in question, ACI-24.060, is an anti-Abeta...Takeda explained in a May 13 release. AC...
Earnings call: Oncternal reports Q1 results and clinical progress
Investing.com· 4 days ago(ONCT) provided a comprehensive update on its business and financial standing in the recent earnings...